|
|
|
|
Clue To Normal-Tension Glaucoma; Herpes Infection And Corneal Transplants
Normal-Tension Herpes Infection And Corneal Transplants Ophthalmology, the journal of the American Academy of Ophthalmology, includes two studies that may influence clinical treatment of serious eye conditions.One study Medical...
|
|
|
Clue To Normal-Tension Glaucoma; Herpes Infection And Corneal Transplants
The July issue of Ophthalmology, the journal of the American Academy of Ophthalmology, includes two studies that may influence clinical treatment of serious eye conditions.One study reports on silent cerebral infarcts (SCI) incidence and...
|
|
|
Applying Novel Biologic Production Methods
click to enlarge Herpes simplex virus infected Vero cells showing rounded cells and syncytia.(BioReliance) A number of leading supply and service companies shared their perspectives on biologics production at a recent SAFC...
|
|
|
Recurrent Lymphocytic Meningitis Positive for Herpes Simplex Virus Type 2
_ Recurrent Lymphocytic Meningitis Positive for Herpes Simplex Virus Type 2.
|
|
|
Dr Mohan of Wyeth bags Emerging Leader Award of PEM, NY
Dr Mohan Bangalore, senior director and site head, Wyeth India has bagged the Pharmaceutical Executive Magazine (New York) Emerging Leader Award.He is the only Indian to receive the honour this year among 27 others in the field. The...
|
|
|
Genital Herpes: Diagnosis, Treatment, and Counseling in the Adolescent Patient
(Click the title below to leave the MDLinx Network and go to the Journal's Website) The Journal for Nurse Practitioners , 06/12/09 Print Save in My Library Free Abstract Bavis MP et al.- An estimated 22% of the U.S. population older...
|
|
|
Herpes facts
Herpes is a disease caused by the herpes simplex virus, or HSV (H-S-V).The virus is usually transmitted by direct contact with an infected individual, including kissing, oral sex, and sexual intercourse, or other situations in...
|
|
|
Herpes Simplex: Initial and Recurrent Infections
Infections in Medicine.26 No. 5 Visual clues to the diagnosis of infectious disease [Infect Med. 2009;26:145-147] Herpes simplex virus (HSV) infections are caused by 2 types of HSV: type 1 (HSV-1) and type 2 (HSV-2).
|
|
|
Prevalence and Clinical Consequences of Herpes Simplex Virus Type 1 DNA in Human Cornea Tissues
(Click the title below to leave the MDLinx Network and go to the Journal's Website) The Journal of Infectious Diseases, 06/02/09 Print Save in My Library Free Abstract Remeijer L et al.- The data presented in this study argue for the...
|
|
|
New Assay For HSV Detection
As a scan of the scientific literature shows, todays herpes tests certainly have their diagnostic strengths.But all have their diagnostic weaknesses, too. Most frequently cited are poor quantitative results, which make tracking a...
|
|
|
What Is Herpes? What Is Genital Herpes?
Genital herpes is a sexually transmitted infected caused by HSV (herpes simplex virus).This virus affects the genitals, the cervix, as well as the skin in other parts of the body. There are two types of herpes simplex...
|
|
|
Herpes simplex virus vector
The invention provides a herpes simplex virus vector comprising deletions in ICP4, ICP27, and UL55.Description of the Invention BRIEF SUMMARY OF THE INVENTION The invention provides a herpes simplex virus vector comprising...
|
|
|
Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
Title: United States Patent: 7,524,674 Inventors: Gambhir; Sanjiv (Portola Valley, CA), Pritha; Ray (Mountain View, CA) Assignee: Stanford University (Palo Alto, CA) Appl.No.: 10/548,146 Filed: March 8, 2004 PCT Filed: March 08, 2004 PCT...
|
|
|
LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
SALEM, Mass., April 29 /PRNewswire/ -- LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected as public relations agency of record by therapeutic vaccine development company, Profectus...
|
|
|
LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
SALEM, Mass., April 29 /PRNewswire/ -- LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected as public relations agency of record by therapeutic vaccine development company, Profectus...
|
|
|
LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
SALEM, Mass., April 29 /PRNewswire/ -- LaVoie Group, a life science-focused strategic communications agency, announced today that it has been selected as public relations agency of record by therapeutic vaccine development company, Profectus...
|
|
|
Profectus Biosciences to Present New Data at 12th Annual Conference on Vaccine Research
Oral Presentation: Title: 'Plasmid-based IL-12 used in combination with in vivo EP and a heterologus pDNA prime, rVSV vector boost vaccination regimen preferentially improves the induction of antigen-specific T cell with a polyfunctional...
|
|
|
Vical Reports Publication of Key Research Findings for Immunotherapeutic Herpes Vaccine
(GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the publication in the May 1 issue of the Journal of General Virology(1) of data from preclinical studies identifying potential targets for development of a herpes ...
|
